0001144204-17-006572.txt : 20170207
0001144204-17-006572.hdr.sgml : 20170207
20170207210050
ACCESSION NUMBER: 0001144204-17-006572
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161208
FILED AS OF DATE: 20170207
DATE AS OF CHANGE: 20170207
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MusclePharm Corp
CENTRAL INDEX KEY: 0001415684
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770664193
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4721 IRONTON STREET
CITY: DENVER
STATE: CO
ZIP: 80239
BUSINESS PHONE: (800) 210-7369
MAIL ADDRESS:
STREET 1: 4721 IRONTON STREET
CITY: DENVER
STATE: CO
ZIP: 80239
FORMER COMPANY:
FORMER CONFORMED NAME: Tone in Twenty
DATE OF NAME CHANGE: 20071018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Drexler Ryan Charles
CENTRAL INDEX KEY: 0001648033
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53166
FILM NUMBER: 17580726
MAIL ADDRESS:
STREET 1: 525 CHALETTE DRIVE
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90201
4/A
1
v458667_4a.xml
OWNERSHIP DOCUMENT
X0306
4/A
2016-12-08
2016-12-12
0
0001415684
MusclePharm Corp
MSLP
0001648033
Drexler Ryan Charles
C/O MUSCLEPHARM CORPORATION
4721 IRONTON STREET, BUILDING A
DENVER
CO
80239
1
1
1
0
See Remarks.
Common Stock
2016-12-08
4
A
0
200000
0.00
A
283434
D
Common Stock
2017-01-01
4
A
0
350000
0.00
A
633434
D
Common Stock
1499408
I
See Footnote
On December 8, 2016, Mr. Drexler was granted 200,000 shares of restricted stock pursuant to the Amended and Restated Executive Employment Agreement between MusclePharm Corporation and Mr. Drexler, dated November 18, 2016 (the "Employment Agreement"). On January 1, 2017, Mr. Drexler was granted 350,000 shares of restricted stock pursuant to the Employment Agreement (the "Second Issuance"). Each grant of restricted stock vests in full upon the first anniversary of its respective grant date. The original Form 4 erroneously reported that the Second Issuance occurred on December 8, 2016. This amendment is being filed to accurately reflect that the Second Issuance occurred on January 1, 2017.
Represents shares of common stock held by Consac LLC ("Consac"). Mr. Drexler is the Chief Executive Officer of Consac and may be deemed to be the indirect beneficial owner (as that term is defined under Rule 13d-3 of the Securities Exchange Act) of the common stock that Consac beneficially owns. Mr. Drexler has the power to direct the voting and disposition of the Issuer's common stock that Consac beneficially owns.
President, Chief Executive Officer and Chairman of the Board of Directors.
/s/ Ryan Charles Drexler
2017-02-07